María Magdalena Vila Vidal, Rosa María López Galera, Yolanda González Irazabal, Carmen Delgado Pecellín, Dolores Rausell Félix, Daisy Castiñeiras Ramos, José María Egea Mellado, Hugo Rocha, Raquel Yahyaoui Macías, Teresa Rodríguez, Vanesa Escribano Hernández, Olaia Rodríguez Fraga, Dolores Bóveda Fontán, José Luis Marín Soria, miembros de la Comisión de Diagnóstico Perinatal de la Sociedad Española de Medicina del Laboratorio
{"title":"Criterios de extracción de muestra en situaciones especiales del cribado neonatal. Revisión","authors":"María Magdalena Vila Vidal, Rosa María López Galera, Yolanda González Irazabal, Carmen Delgado Pecellín, Dolores Rausell Félix, Daisy Castiñeiras Ramos, José María Egea Mellado, Hugo Rocha, Raquel Yahyaoui Macías, Teresa Rodríguez, Vanesa Escribano Hernández, Olaia Rodríguez Fraga, Dolores Bóveda Fontán, José Luis Marín Soria, miembros de la Comisión de Diagnóstico Perinatal de la Sociedad Española de Medicina del Laboratorio","doi":"10.1016/j.labcli.2019.01.006","DOIUrl":null,"url":null,"abstract":"<div><p>The most significant breakthrough in the newborn screening (NBS) programs was the introduction of the tandem mass spectrometry (MS-MS) to the laboratory, which makes it possible to detect multiple disorders. However, it is difficult to choose the ideal time for the specimen collection, particularly in preterm, low birth weight, and sick newborns.</p><p>The aim of this study was to revise the protocols, in national and international programs for specimen collection in these newborns.</p><p>Data were collected from web pages of public health, internet searches, and contact with the laboratories.</p><p>The results showed a great disparity in criteria for a new specimen collection, as well as among different centres within a country. It has been difficult to obtain this information from many countries in Africa, Asia, and Latin America.</p><p>Although an increasing number of laboratories follow the recommendations of the Clinical and Laboratory Standards Institute or other international guidelines, the increased cost involved makes standardisation difficult.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista del Laboratorio Clínico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1888400819300273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The most significant breakthrough in the newborn screening (NBS) programs was the introduction of the tandem mass spectrometry (MS-MS) to the laboratory, which makes it possible to detect multiple disorders. However, it is difficult to choose the ideal time for the specimen collection, particularly in preterm, low birth weight, and sick newborns.
The aim of this study was to revise the protocols, in national and international programs for specimen collection in these newborns.
Data were collected from web pages of public health, internet searches, and contact with the laboratories.
The results showed a great disparity in criteria for a new specimen collection, as well as among different centres within a country. It has been difficult to obtain this information from many countries in Africa, Asia, and Latin America.
Although an increasing number of laboratories follow the recommendations of the Clinical and Laboratory Standards Institute or other international guidelines, the increased cost involved makes standardisation difficult.